AST 487
Product Specifications
UNSPSC Description
AST 487 is a RET kinase inhibitor with IC50 of 880 nM, inhibits RET autophosphorylation and activation of downstream effectors, also inhibits Flt-3 with IC50 of 520 nM.
Target Antigen
Bcr-Abl; c-Kit; FLT3; RET; VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AST-487.html
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(NC1=CC=C(OC2=NC=NC(NC)=C2)C=C1)NC3=CC=C(CN4CCN(CC)CC4)C(C(F)(F)F)=C3
Molecular Weight
529.56
References & Citations
[1]Akeno-Stuart N, et al. The RET Kinase Inhibitor NVP-AST487 Blocks Growth and Calcitonin Gene Expression through Distinct Mechanisms in Medullary Thyroid Cancer Cells. Cancer Res. 2007 Jul 15;67(14):6956-64.|[2]Weisberg E, et al. Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells. Blood. 2008 Dec 15;112(13):5161-70.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-15002/AST-487-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-15002/AST-487-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
630124-46-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E45H52241M4-20 20 ug
CD96 Protein, Human, Recombinant (hFc & AVI Tag), Biotinylated
Ask
View Details 
ARP38113_P050-FITC 100 µL
Hoxb1 Antibody - N-terminal region: FITC (ARP38113_P050-FITC)
Ask
View Details